My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 98

    1.

    Cost-efficacy of surgically induced weight loss for the management of type 2 diabetes: a randomized controlled trial.

    Keating CL, Dixon JB, Moodie ML, Peeters A, Playfair J, O'Brien PE.

    Diabetes Care. 2009 Apr;32(4):580-4. Epub 2009 Jan 26.PMID: 19171726 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis.

    Keating CL, Dixon JB, Moodie ML, Peeters A, Bulfone L, Maglianno DJ, O'Brien PE.

    Diabetes Care. 2009 Apr;32(4):567-74. Epub 2009 Jan 26.PMID: 19171720 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial.

    Dixon JB, O'Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, Proietto J, Bailey M, Anderson M.

    JAMA. 2008 Jan 23;299(3):316-23.PMID: 18212316 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Economic evaluation of orlistat in overweight and obese patients with type 2 diabetes mellitus.

    Maetzel A, Ruof J, Covington M, Wolf A.

    Pharmacoeconomics. 2003;21(7):501-12.PMID: 12696990 [PubMed - indexed for MEDLINE]Related articles

    5.

    [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation]

    Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

    Encephale. 2005 Mar-Apr;31(2):235-46. Review. French. PMID: 15959450 [PubMed - indexed for MEDLINE]Related articles

    6.

    The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trial.

    Grant A, Wileman S, Ramsay C, Bojke L, Epstein D, Sculpher M, Macran S, Kilonzo M, Vale L, Francis J, Mowat A, Krukowski Z, Heading R, Thursz M, Russell I, Campbell M; REFLUX Trial Group.

    Health Technol Assess. 2008 Sep;12(31):1-181, iii-iv.PMID: 18796263 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.

    Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC, Smith WC, Jung RT, Campbell MK, Grant AM.

    Health Technol Assess. 2004 May;8(21):iii-iv, 1-182. Review.PMID: 15147610 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.

    Main C, Bojke L, Griffin S, Norman G, Barbieri M, Mather L, Stark D, Palmer S, Riemsma R.

    Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. Review.PMID: 16545208 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data.

    Yu AP, Wu EQ, Birnbaum HG, Emani S, Fay M, Pohl G, Wintle M, Yang E, Oglesby A.

    Curr Med Res Opin. 2007 Sep;23(9):2157-69. Review.PMID: 17669232 [PubMed - indexed for MEDLINE]Related articles

    10.

    Cost-effectiveness analysis of laparoscopic gastric bypass, adjustable gastric banding, and nonoperative weight loss interventions.

    Salem L, Devlin A, Sullivan SD, Flum DR.

    Surg Obes Relat Dis. 2008 Jan-Feb;4(1):26-32. Epub 2007 Dec 19.PMID: 18069075 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The incremental costs of recommended therapy versus real world therapy in type 2 diabetes patients.

    Crivera C, Suh DC, Huang ES, Cagliero E, Grant RW, Vo L, Shin HC, Meigs JB.

    Curr Med Res Opin. 2006 Nov;22(11):2301-11.PMID: 17076990 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group.

    Gray A, Raikou M, McGuire A, Fenn P, Stevens R, Cull C, Stratton I, Adler A, Holman R, Turner R.

    BMJ. 2000 May 20;320(7246):1373-8.PMID: 10818026 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Review of meta-analytic comparisons of bariatric surgery with a focus on laparoscopic adjustable gastric banding.

    Cunneen SA.

    Surg Obes Relat Dis. 2008 May-Jun;4(3 Suppl):S47-55. Review.PMID: 18501315 [PubMed - indexed for MEDLINE]Related articles

    14.

    The cost effectiveness of orlistat in a 1-year weight-management programme for treating overweight and obese patients in Sweden : a treatment responder approach.

    Hertzman P.

    Pharmacoeconomics. 2005;23(10):1007-20. Review.PMID: 16235974 [PubMed - indexed for MEDLINE]Related articles

    15.

    Impact of bariatric surgery on type 2 diabetes.

    Meneghini LF.

    Cell Biochem Biophys. 2007;48(2-3):97-102. Review.PMID: 17709879 [PubMed - indexed for MEDLINE]Related articles

    16.

    Clinical effectiveness and cost-effectiveness of laparoscopic surgery for colorectal cancer: systematic reviews and economic evaluation.

    Murray A, Lourenco T, de Verteuil R, Hernandez R, Fraser C, McKinley A, Krukowski Z, Vale L, Grant A.

    Health Technol Assess. 2006 Nov;10(45):1-141, iii-iv. Review.PMID: 17083853 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

    Shepherd J, Jones J, Takeda A, Davidson P, Price A.

    Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.PMID: 16904047 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity: a 4-year case-controlled study.

    Pontiroli AE, Folli F, Paganelli M, Micheletto G, Pizzocri P, Vedani P, Luisi F, Perego L, Morabito A, Bressani Doldi S.

    Diabetes Care. 2005 Nov;28(11):2703-9.PMID: 16249543 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The comparative effects of bariatric surgery on weight and type 2 diabetes.

    Levy P, Fried M, Santini F, Finer N.

    Obes Surg. 2007 Sep;17(9):1248-56. Review.PMID: 18074502 [PubMed - indexed for MEDLINE]Related articles

    20.

    Cost-effectiveness and budget impact of obesity surgery in patients with type-2 diabetes in three European countries.

    Ackroyd R, Mouiel J, Chevallier JM, Daoud F.

    Obes Surg. 2006 Nov;16(11):1488-503.PMID: 17132416 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity